In this free webinar, learn how the PPD clinical research business of Thermo Fisher Scientific is at the forefront of applying artificial intelligence (AI) to clinical trials in the focus areas of clinical site selection, forecasting and resourcing and patient recruitment and enrollment. The featured speakers will discuss how the business is strategically investing in the use of AI and new technologies across all aspects of the clinical study lifecycle, ensuring a connected experience for customers. Attendees will learn how advanced AI tools are crucial for managing complex trials, including decentralized trials and rare disease studies. The speakers will also share how the business is incorporating generative AI into workflows to streamline manual processes and improve efficiency.

TORONTO, May 16, 2024 /PRNewswire-PRWeb/ — Attend this informative webinar that will explore how artificial intelligence (AI) is being used to optimize key aspects of clinical trial management.

During this webinar, the speakers will discuss the application of AI in clinical site selection, forecasting and resourcing and patient recruitment and enrollment. Attendees will learn about innovative AI solutions that can revolutionize these critical areas, enabling faster, more accurate and confident decision-making processes.

Furthermore, they will focus on required strategic investments in all aspects of the clinical study lifecycle. By adopting a comprehensive approach, the PPD clinical research business of Thermo Fisher Scientific aims to provide a connected experience that maximizes efficiencies, prioritizes quality and minimizes potential bottlenecks.

As clinical trials become increasingly complex, particularly with decentralized trials and rare disease studies, advanced AI tools are essential for effectively managing these challenges. In this webinar, attendees will get to discover how AI capabilities can address these complexities and ensure streamlined operations and improved study outcomes.

In addition, the speakers will discuss the integration of generative AI into workflows. By leveraging generative AI, content drafting for regulatory documents and training materials can be accelerated. While maintaining regulatory standards with human oversight, generative AI serves as a valuable workflow acceleration tool, enhancing efficiency and productivity.

Register for this webinar and gain valuable insights into using AI for clinical trials to improve trial efficiencies, ultimately driving better outcomes and advancing medical research more quickly.

Join experts from the PPD clinical research business of Thermo Fisher Scientific, Dave Hiltbrand, Associate Director of Data Science; Nikki McLean, Operational Strategy Senior Lead; and Tim Rich, VP, Digital and Decentralized Solutions, for the live webinar on Wednesday, June 5, 2024, at 12pm EDT (9am PDT).

For more information, or to register for this event, visit Leveraging AI for Clinical Trial Efficiencies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/leveraging-ai-for-clinical-trial-efficiencies-upcoming-webinar-hosted-by-xtalks-302147355.html

SOURCE Xtalks